These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31212213)

  • 1. Integration of screening, assessment, and treatment for cannabis and other drug use disorders in primary care: An evaluation in three pilot sites.
    Richards JE; Bobb JF; Lee AK; Lapham GT; Williams EC; Glass JE; Ludman EJ; Achtmeyer C; Caldeiro RM; Oliver M; Bradley KA
    Drug Alcohol Depend; 2019 Aug; 201():134-141. PubMed ID: 31212213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between cannabis use disorder symptom severity and probability of clinically-documented diagnosis and treatment in a primary care sample.
    Matson TE; Williams EC; Lapham GT; Oliver M; Hallgren KA; Bradley KA
    Drug Alcohol Depend; 2023 Oct; 251():110946. PubMed ID: 37688980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric Performance of a Substance Use Symptom Checklist to Help Clinicians Assess Substance Use Disorder in Primary Care.
    Matson TE; Hallgren KA; Lapham GT; Oliver M; Wang X; Williams EC; Bradley KA
    JAMA Netw Open; 2023 May; 6(5):e2316283. PubMed ID: 37234003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine Assessment of Symptoms of Substance Use Disorders in Primary Care: Prevalence and Severity of Reported Symptoms.
    Sayre M; Lapham GT; Lee AK; Oliver M; Bobb JF; Caldeiro RM; Bradley KA
    J Gen Intern Med; 2020 Apr; 35(4):1111-1119. PubMed ID: 31974903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Test-retest reliability of DSM-5 substance use symptom checklists used in primary care and mental health care settings.
    Hallgren KA; Matson TE; Oliver M; Wang X; Williams EC; Bradley KA
    Drug Alcohol Depend; 2024 Mar; 256():111108. PubMed ID: 38295510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity of the Single-Item Screen-Cannabis (SIS-C) for Cannabis Use Disorder Screening in Routine Care.
    Matson TE; Lapham GT; Bobb JF; Oliver M; Hallgren KA; Williams EC; Bradley KA
    JAMA Netw Open; 2022 Nov; 5(11):e2239772. PubMed ID: 36318205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of Healthcare Effectiveness Data and Information Set (HEDIS) initiation and engagement in treatment among patients with cannabis use disorders in 7 US health systems.
    Lapham GT; Campbell CI; Yarborough BJH; Hechter RC; Ahmedani BK; Haller IV; Kline-Simon AH; Satre DD; Loree AM; Weisner C; Binswanger IA
    Subst Abus; 2019; 40(3):268-277. PubMed ID: 30657438
    [No Abstract]   [Full Text] [Related]  

  • 8. Cannabis use disorder among people using cannabis daily/almost daily in the United States, 2002-2016.
    Santaella-Tenorio J; Levy NS; Segura LE; Mauro PM; Martins SS
    Drug Alcohol Depend; 2019 Dec; 205():107621. PubMed ID: 31698323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cigarette use is increasing among people with illicit substance use disorders in the United States, 2002-14: emerging disparities in vulnerable populations.
    Weinberger AH; Gbedemah M; Wall MM; Hasin DS; Zvolensky MJ; Goodwin RD
    Addiction; 2018 Apr; 113(4):719-728. PubMed ID: 29265574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DSM-5 cannabis use disorder, substance use and DSM-5 specific substance-use disorders: Evaluating comorbidity in a population-based sample.
    Hayley AC; Stough C; Downey LA
    Eur Neuropsychopharmacol; 2017 Aug; 27(8):732-743. PubMed ID: 28663122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Greater Prevalence of Proposed ICD-11 Alcohol and Cannabis Dependence Compared to ICD-10, DSM-IV, and DSM-5 in Treated Adolescents.
    Chung T; Cornelius J; Clark D; Martin C
    Alcohol Clin Exp Res; 2017 Sep; 41(9):1584-1592. PubMed ID: 28667763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screen of drug use: Diagnostic accuracy for cannabis use disorder.
    Tiet QQ; Leyva YE; Browne K; Moos RH
    Addict Behav; 2019 Aug; 95():184-188. PubMed ID: 30933714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of DSM-IV and DSM-5 alcohol, cocaine, opioid, and cannabis use disorders in a largely substance dependent sample.
    Peer K; Rennert L; Lynch KG; Farrer L; Gelernter J; Kranzler HR
    Drug Alcohol Depend; 2013 Jan; 127(1-3):215-9. PubMed ID: 22884164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabis use and cannabis use disorders among individuals with mental illness.
    Lev-Ran S; Le Foll B; McKenzie K; George TP; Rehm J
    Compr Psychiatry; 2013 Aug; 54(6):589-98. PubMed ID: 23375264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical conditions of primary care patients with documented cannabis use and cannabis use disorder in electronic health records: a case control study from an academic health system in a medical marijuana state.
    Padwa H; Huang D; Mooney L; Grella CE; Urada D; Bell DS; Bass B; Boustead AE
    Subst Abuse Treat Prev Policy; 2022 May; 17(1):36. PubMed ID: 35527269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis use disorders among adults in the United States during a time of increasing use of cannabis.
    Compton WM; Han B; Jones CM; Blanco C
    Drug Alcohol Depend; 2019 Nov; 204():107468. PubMed ID: 31586809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DSM-5 substance use disorders among adult primary care patients: Results from a multisite study.
    Wu LT; McNeely J; Subramaniam GA; Brady KT; Sharma G; VanVeldhuisen P; Zhu H; Schwartz RP
    Drug Alcohol Depend; 2017 Oct; 179():42-46. PubMed ID: 28753480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of substance use screening in rural federally-qualified health center clinics identified high rates of unhealthy alcohol and cannabis use among adult primary care patients.
    McNeely J; McLeman B; Gardner T; Nesin N; Amarendran V; Farkas S; Wahle A; Pitts S; Kline M; King J; Rosa C; Marsch L; Rotrosen J; Hamilton L
    Addict Sci Clin Pract; 2023 Sep; 18(1):56. PubMed ID: 37726839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can initial experiences with drugs predict future drug abuse risks?
    Varshneya NB; Dunn KE; Grubb CJ; Okobi SI; Huhn AS; Bergeria CL
    Exp Clin Psychopharmacol; 2023 Feb; 31(1):186-193. PubMed ID: 35266780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construct validity of DSM-5 cannabis use disorder diagnosis and severity levels in adults with problematic substance use.
    Fink DS; Shmulewitz D; Mannes ZL; Stohl M; Livne O; Wall M; Hasin DS
    J Psychiatr Res; 2022 Nov; 155():387-394. PubMed ID: 36182768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.